Home › Therapeutic areas › Oncology › Multiple Myeloma
Multiple Myeloma (10 companies)
Companies with an active program in Multiple Myeloma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics | ImmunologyOncology Rare | 1 | Phase 2 | 10 |
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| CCCC | C4 Therapeutics | Oncology | 1 | Phase 2 | 2 |
| CRBU | Caribou Biosciences | Oncology | 1 | Phase 1 | 4 |
| RNAC | Cartesian Therapeutics | ImmunologyNeurology+1 Rare | 1 | Phase 3 | 4 |
| CLRB | Cellectar Biosciences | Oncology | 1 | Phase 2 | 6 |
| FHTX | Foghorn Therapeutics | Oncology | 1 | Phase 1 | 5 |
| LEGN | Legend Biotech | Oncology Rare | 1 | Approved | 8 |
| SANA | Sana Biotechnology | MetabolicOncology | 1 | Phase 1 | 4 |
| SLS | SELLAS Life Sciences Group | Oncology | 1 | Phase 3 | 9 |
No companies match.